Physician profile
Nathan Grant Warner
NPI 1659589133
$9,476.32
in general payments reported to CMS, 2019-2025
30 companies · $2,348 in 2025
The $2,348 reported for 2025 was more than what 94% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,298 · 2022: $1,268 · 2023: $2,397 · 2024: $2,166 · 2025: $2,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,817 · Education: $94.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,816.77 |
| Education | $94.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,226.13 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,363.19 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $997.66 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $490.43 | 2021-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $436.82 | 2021-2025 | Qelbree, Qelbree |
| Axsome Therapeutics, INC. | $418.80 | 2022-2025 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $385.64 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $381.76 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $378.24 | 2021-2025 | Invega Sustenna, Spravato |
| Harmony Biosciences LLC | $364.04 | 2022-2025 | Wakix |
| Teva Pharmaceuticals USA, INC. | $249.20 | 2022-2025 | Uzedy, Austedo Xr, Austedo |
| Jazz Pharmaceuticals INC. | $237.67 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $210.00 | 2021-2025 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $202.98 | 2024-2025 | Cobenfy |
| Indivior INC. | $166.91 | 2021-2024 | Perseris |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $138.42 | 2023-2025 | Dyanavel Xr |
| Bausch Health US, LLC | $126.20 | 2021-2023 | Wellbutrin, Aplenzin |
| Vanda Pharmaceuticals INC. | $125.56 | 2022-2025 | Fanapt, Hetlioz |
| Sunovion Pharmaceuticals INC. | $104.16 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $88.45 | 2023-2024 | Quviviq |
| Corium, LLC | $78.35 | 2022-2025 | Azstarys |
| Avanir Pharmaceuticals, INC. | $45.91 | 2022 | |
| Merck Sharp & Dohme LLC | $43.60 | 2022-2023 | Belsomra |
| Ironshore Pharmaceuticals INC. | $42.83 | 2021-2022 | |
| Noven Therapeutics, LLC | $40.92 | 2024 | Xelstrym, Secuado |
| Biogen, INC. | $38.50 | 2025 | Zurzuvae |
| Neos Therapeutics, LP | $37.05 | 2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $22.22 | 2025 | Jornay Pm |
| Noven Pharmaceuticals, INC. | $19.39 | 2024 | Xelstrym |
| Almatica Pharma LLC | $15.29 | 2023 | Sertraline Hcl, Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.